Regulation of OCT2 transcriptional repression by histone acetylation in renal cell carcinoma
出版年份 2019 全文链接
标题
Regulation of OCT2 transcriptional repression by histone acetylation in renal cell carcinoma
作者
关键词
-
出版物
Epigenetics
Volume -, Issue -, Pages 1-13
出版商
Informa UK Limited
发表日期
2019-05-15
DOI
10.1080/15592294.2019.1615354
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Combining Epigenetic and Immunotherapy to Combat Cancer
- (2016) Katherine B. Chiappinelli et al. CANCER RESEARCH
- HDACs and HDAC Inhibitors in Cancer Development and Therapy
- (2016) Yixuan Li et al. Cold Spring Harbor Perspectives in Medicine
- Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma
- (2015) Deepanwita Sengupta et al. Epigenetics
- EAU Guidelines on Renal Cell Carcinoma: 2014 Update
- (2015) Borje Ljungberg et al. EUROPEAN UROLOGY
- Retrospective analysis of docetaxel, oxaliplatin plus fluorouracil compared with epirubicin, cisplatin and fluorouracil as first-line therapy for advanced gastric cancer
- (2014) Zhihua Yao et al. JOURNAL OF CHEMOTHERAPY
- Histone deacetylases and cancer
- (2012) Bruna Barneda-Zahonero et al. Molecular Oncology
- Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy
- (2011) Min-Yu Chen et al. CANCER
- Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)
- (2010) H Burger et al. BRITISH JOURNAL OF PHARMACOLOGY
- A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer
- (2010) Fang Fang et al. CANCER
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation
- (2010) Qihuang Jin et al. EMBO JOURNAL
- EAU Guidelines on Renal Cell Carcinoma: The 2010 Update
- (2010) Börje Ljungberg et al. EUROPEAN UROLOGY
- Acquired vorinostat resistance shows partial cross-resistance to ‘second-generation’ HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities
- (2009) Konstantin J. Dedes et al. ANTI-CANCER DRUGS
- Decitabine Effect on Tumor Global DNA Methylation and Other Parameters in a Phase I Trial in Refractory Solid Tumors and Lymphomas
- (2009) D. J. Stewart et al. CLINICAL CANCER RESEARCH
- High Histone Deacetylase 7 (HDAC7) Expression Is Significantly Associated with Adenocarcinomas of the Pancreas
- (2008) Mehdi Ouaïssi et al. ANNALS OF SURGICAL ONCOLOGY
- Genetics and epigenetics of renal cell cancer
- (2008) Marcella M.L. Baldewijns et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- HDAC expression and clinical prognosis in human malignancies
- (2008) Wilko Weichert CANCER LETTERS
- Significance of Organic Cation Transporter 3 (SLC22A3) Expression for the Cytotoxic Effect of Oxaliplatin in Colorectal Cancer
- (2008) S. Yokoo et al. DRUG METABOLISM AND DISPOSITION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started